Millennium was founded in 1993 as a genomics company (Millennium Pharmaceuticals, Inc). We've grown from that small genomics start-up into a fully-integrated biopharmaceutical company with an innovative pipeline of novel molecules. Our Company currently employs approximately 1,000 people at its headquarters in Cambridge, MA.

In May 2008, Millennium was acquired by Takeda Pharmaceutical Company Limited and now we are Millennium: The Takeda Oncology Company. We continue to be an entrepreneurial culture of best and brightest talent, who passionately strive to exceed the ability of our competition in serving the needs of cancer patients worldwide.

Founded in 1781 in Osaka, Japan, Takeda is nearly as old as the United States. They are the largest pharmaceutical company in Asia and have a core culture that honors integrity, tenacity and audacious progress. Although vastly different in size and age, our companies share a tremendous commitment to achieve breakthroughs against cancer so that we can deliver important new therapies to patients to provide a better chance for a good life.

By creating an oncology center of excellence at Millennium, Takeda has enabled us to apply a sole focus on cancer that benefits from a larger pipeline of promising molecules, greater resources for discovery and development, and a bold new vision to become a top three global oncology company by 2020. As Millennium: The Takeda Oncology Company, we're up to that challenge.